Study Status: Not yet recruiting
Recruit Status: Not yet recruiting
Study Type: Interventional
Official Title: Double-blind, Placebo-controlled, Cross-over Trial of Ketotifen in Children and Adolescents With Functional Dyspepsia in Association With Duodenal Eosinophilia
Brief Summary: This study is a double-blind, placebo -controlled, cross-over trial of ketotifen in children ages 8 through 17 inclusive that have a diagnosis of Functional Dyspepsia and have had continued pain despite acid reduction therapy in combination with montelukast. This study is 147 days for subjects responsive to the ketotifen and 63 days for those who are not. The study includes scheduled visits including a physical, blood draws, and questionaires.